About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 486568, 12 pages
http://dx.doi.org/10.1155/2012/486568
Research Article

The Potential Utility of Curcumin in the Treatment of HER-2-Overexpressed Breast Cancer: An In Vitro and In Vivo Comparison Study with Herceptin

1Comprehensive Breast Cancer Center, Changhua Christian Hospital, Changhua 50006, Taiwan
2Department and Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei 11221, Taiwan
3Department of Pharmacology, Changhua Christian Hospital, Changhua 50006, Taiwan
4School of Medicine, College of Health Care and Management, Chung Shan Medical University, Taichung 40201, Taiwan
5School of Nutrition, College of Health Care and Management, Chung Shan Medical University, Taichung 40201, Taiwan
6Division of General Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei 11217, Taiwan
7School of Medicine, National Yang-Ming University, Taipei 11221, Taiwan
8Department of Pharmacology, School of Pharmacology, China Medical University, Taichung 40402, Taiwan

Received 11 November 2010; Revised 21 March 2011; Accepted 2 May 2011

Academic Editor: Jae Youl Cho

Copyright © 2012 Hung-Wen Lai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Hung-Wen Lai, Su-Yu Chien, Shou-Jen Kuo, et al., “The Potential Utility of Curcumin in the Treatment of HER-2-Overexpressed Breast Cancer: An In Vitro and In Vivo Comparison Study with Herceptin,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 486568, 12 pages, 2012. doi:10.1155/2012/486568